Trust Size
$8M
Peak Price
$307.50
Current Price
$2.25
Return
-77.5%
Price Journey
What Happened
Cardio Diagnostics is an artificial intelligence-powered precision cardiovascular diagnostics company using epigenomic technology to detect heart disease through blood tests.
Cardio Diagnostics went public through a SPAC merger and trades under CDIO. The company is developing blood-based tests that use epigenomic (DNA methylation) biomarkers powered by AI to assess cardiovascular disease risk. Despite an innovative approach, the company has reported going concern warnings and the stock has declined significantly.
Timeline
2021-11-10
S-1 Registration Filed
🔀 Reverse Stock Split
Reverse split ratio: . Reverse splits are used to avoid delisting but destroy shareholder value through the illusion of a higher stock price.
SEC Filing Details
CIK Number
1870144
Total SEC Filings
274
State of Incorporation
DE
Last Filing Date
2026-03-13
Business Location
Dover, DE
Trust/Asset Size
$8M
Data sourced from SEC EDGAR Company Facts API and EFTS search index.
📄 SEC Filings
View all EDGAR filings for Cardio Diagnostics Holdings